Abstract
The transurethral resection of bladder tumor (TURBT) remains the most widely used method in the surgical treatment of the non-muscle invasive bladder tumor (NMIBT). Despite its popularity, the laser technique has been widely used in urology as an alternative, via the application of transurethral laser enucleation of bladder tumor. The aim of the present study was to compare the efficacy and feasibility between transurethral laser enucleation and transurethral resection of bladder tumor. A systematic search of the following databases was conducted: PubMed, Wed of Science, Cochrane Library, EMBASE, Google scholar, and Medline. The search included studies up to the 1st of January 2017. The outcomes of interest that were used in order to assess the two techniques included operation time, catheterization time, hospitalization time, obturator nerve reflex, bladder perforation, bladder irritation, 24-month-recurrence rate, and the postoperative adjuvant intravesical chemotherapy. A total of 13 trials with 2012 participants were included, of which 975 and 1037 underwent transurethral laser enucleation and transurethral resection of bladder tumor, respectively. No significant difference was noted in the operation time between the two groups, although significant differences were reported for the variables catheterization time, hospitalization time, obturator nerve reflex, bladder perforation, bladder irritation, and 24-month-recurrence rate. In the mitomycin and epirubicin subgroups, no significant differences were observed in the laser enucleation and TURBT methods with regard to the 24-month-recurrence rate. The laser enucleation was superior to TURBT with regard to the parameters obturator nerve reflex, bladder perforation, catheterization time, hospitalization time, and 24-month-recurrence rate. Moreover, laser enucleation can offer a more accurate result of the tumor’s pathological stage and grade.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. Ca A Cancer J Clin 66(1):7–30
Sanli O, Dobruch J, Knowles MA et al (2017) Bladder cancer, 2017. Nat Rev Dis Primers 3:1–19
Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374(9685):239
Zarrabi A, Gross AJ (2011) The evolution of lasers in urology. Ther Adv Urol 3(2):81–89
Phillips B (2004) GRADE: levels of evidence and grades of recommendation. Arch Dis Child 89:489
Clarke MRH (2001) Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 357:1728
D'Souza N, Verma A (2016) Holmium laser transurethral resection of bladder tumor: our experience. Urol Ann 8(4):439
Tao W, Yang D, Shan Y et al (2013) Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer. J X-ray sci and technol 21(2):309–316
Zhang XR, Feng C, Zhu WD et al (2015) Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study. Photomed Laser Surg 33(10):517–523
Migliari R, Buffardi A, Ghabin H (2015) Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol 29(11):1258
Huang J-H, Hu Y-Y, Liu M et al (2016) Comparative study of 2 um laser versus Holmium laser for the resection of non-muscle invasive bladder cancer. Int J Clin Exp Med 9(12):23618–23623
Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33(12):1937–1943
Yang D, Xue B, Zang Y, et al (2014) Efficacy and safety of potassium-titanyl-phosphate laser vaporization for clinically non-muscle invasive bladder cancer. Urol J 11(1):1258–1263
Chen Z, Guo SW, Tang YQ et al (2010) Clinical obervation on 2 micron laser for non-muscle -invasive bladder tumor treatment: single-center experience. World J Urol 28:157–161
Xishuang S, Deyong Y, Xiangyu C et al (2010) Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 24(1):69–73
Zhu Y, Jiang X, Zhang J et al (2008) Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 72(3):608–612
Liu H, Wu J, Xue S et al (2013) Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res 41(4):984
Chen X, Liao J, Chen L et al (2015) En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial.World. J Urol 33(7):989–995
Chen J, Zhao Y, Wang S et al (2016) Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Laser Surg Med 48(9):859–865
Smith AB, Deal AM, Woods ME et al (2014) Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int 114(5):719–726
Burger M, Catto JW, Dalbagni G et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241
Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 14(12):1937–1943
Wolters M, Kramer MW, Becker JU et al (2011) Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol 29(4):429–432
Kramer MW, Abdelkawi IF, Wolters M et al (2014) Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer. Minim Invasive Ther Allied Technol 23(4):206
The role of funding source
The work was supported by Independent innovation research fund of Huazhong University of Science and Technology, China; Award Number: 1802030.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethnical approval
All analyses were based on previous published studies, thus no ethical approval and patient consent are required.
Conflict of interest
The authors declare that they have no competing interest.
Rights and permissions
About this article
Cite this article
Yang, H., Wang, N., Han, S. et al. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis. Lasers Med Sci 32, 2005–2012 (2017). https://doi.org/10.1007/s10103-017-2308-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2308-5